Total Payments
$3,283
2020 Payments
$365.64
Companies
23
Transactions
137
Medicare Patients
146
Medicare Billing
$5,875
Payment Breakdown by Category
Food & Beverage$3,283 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,283 | 137 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $431.24 | 13 | $0 (2020) |
| AbbVie, Inc. | $419.62 | 17 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $378.32 | 4 | $0 (2019) |
| Celgene Corporation | $322.13 | 13 | $0 (2019) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $285.55 | 11 | $0 (2020) |
| PFIZER INC. | $268.83 | 9 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $203.50 | 12 | $0 (2020) |
| LEO Pharma Inc. | $158.73 | 9 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $153.82 | 10 | $0 (2020) |
| Lilly USA, LLC | $92.36 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $365.64 | 16 | Amgen Inc. ($159.47) |
| 2019 | $834.65 | 36 | Celgene Corporation ($167.32) |
| 2018 | $1,237 | 47 | AbbVie, Inc. ($255.02) |
| 2017 | $846.07 | 38 | PFIZER INC. ($180.01) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: DERMATOLOGY | ||||||
| 03/17/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | ALTRENO (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: DERMATOLOGY | ||||||
| 03/12/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: DERMATOLOGY | ||||||
| 03/10/2020 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology | ||||||
| 03/06/2020 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: DERMATOLOGY | ||||||
| 03/04/2020 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $14.64 | General |
| 03/03/2020 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 02/26/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $116.76 | General |
| Category: Inflammation | ||||||
| 02/12/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: DERMATOLOGY | ||||||
| 02/12/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/11/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Inflammation | ||||||
| 02/05/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Immunology | ||||||
| 02/04/2020 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $17.68 | General |
| 01/23/2020 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Immunology | ||||||
| 01/08/2020 | Sun Pharmaceutical Industries Inc. | ABSORICA LD (Drug) | Food and Beverage | Cash or cash equivalent | $14.76 | General |
| Category: Dermatology | ||||||
| 01/07/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation | ||||||
| 12/18/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $18.07 | General |
| 12/11/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/25/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: DERMATOLOGY | ||||||
| 10/16/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/08/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: DERMATOLOGY | ||||||
| 09/23/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: DERMATOLOGY | ||||||
| 09/21/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Immunology | ||||||
| 09/18/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: DERMATOLOGY | ||||||
| 08/28/2019 | Sun Pharmaceutical Industries Inc. | ILUMYA (Biological) | Food and Beverage | Cash or cash equivalent | $14.74 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 146 | 217 | $22,760 | $5,875 |
Total Patients
146
Total Services
217
Medicare Billing
$5,875
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 45 | $6,300 | $1,702 | 27.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 28 | 30 | $3,745 | $1,048 | 28.0% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 13 | 15 | $3,430 | $955.46 | 27.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 18 | 18 | $2,985 | $845.65 | 28.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $2,700 | $534.39 | 19.8% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 18 | 21 | $1,855 | $480.73 | 25.9% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 15 | 75 | $1,745 | $308.83 | 17.7% |
About Dr. Nicholas Bruno, MD
Dr. Nicholas Bruno, MD is a Dermatopathology healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053413484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Bruno, MD has received a total of $3,283 in payments from pharmaceutical and medical device companies, with $365.64 received in 2020. These payments were reported across 137 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,283).
As a Medicare-enrolled provider, Bruno has provided services to 146 Medicare beneficiaries, totaling 217 services with total Medicare billing of $5,875. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location Lincoln, RI
- Active Since 09/05/2006
- Last Updated 04/03/2019
- Taxonomy Code 207ND0900X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053413484
Products in Payments
- Humira (Biological) $401.22
- Otezla (Drug) $364.26
- Tremfya (Drug) $292.89
- Enbrel (Biological) $271.77
- EUCRISA (Drug) $268.83
- COSENTYX (Biological) $153.11
- ENSTILAR (Drug) $143.56
- TALTZ (Drug) $92.36
- ILUMYA (Biological) $92.06
- DUOBRII (Drug) $92.03
- STELARA (Biological) $85.43
- Finacea (Drug) $84.85
- DORYX (Drug) $81.81
- SILIQ (Drug) $65.61
- Avar (Drug) $62.32
- Exelderm (Drug) $53.22
- Veltin (Drug) $37.16
- REMICADE (Biological) $34.94
- Cimzia (Drug) $33.99
- ILUMYA (tildrakizumab-asmn) injection (Biological) $33.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.